Download PDF
Synlett 2009(16): 2625-2628  
DOI: 10.1055/s-0029-1218018
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Furanoid Amino Acids via a Domino Michael-Aldol-Addition-Cyclization Approach

Uli Kazmaier*, Christian Schmidt
Institut für Organische Chemie, Universität des Saarlandes, 66123 Saarbrücken, Germany
Fax: +49(681)3022409; e-Mail: u.kazmaier@mx.uni-saarland.de;
Further Information

Publication History

Received 7 July 2009
Publication Date:
10 September 2009 (online)

    Permissions and Reprints All articles of this category

Abstract

Chelated enolates undergo Michael addition towards halogenated α,β-unsaturated esters in a highly stereoselective fashion. The enolates formed can be trapped with aldehydes in a stereoselective aldol reaction, before subsequent cyclization gives rise to substituted furanoid amino acids. Up to for stereogenic centers can be formed in this new one-pot reaction.

Key words

aldol reaction - amino acids - chelates - cyclization - domino reaction - Michael addition

    References and Notes

  • Reviews:
  • 1a Bioactive Marine Natural Products   Bhakuni DS. Rawat DS. Rawar DS. Springer; New York: 2005. 
    Google Scholar
  • 1b Blunt JW. Copp BR. Hu W.-P. Munro MHG. Northcote PT. Prinsep MR. Nat. Prod. Rep.  2008,  25:  35 ; and references cited therein
    Google Scholar
  • 2a Bergmann W. Feeney RJ. J. Am. Chem. Soc.  1950,  72:  2809 
    Google Scholar
  • 2b Quinn RJ. Gregson RP. Cool AF. Bartlett RT. Tetrahedron Lett.  1980,  21:  567 
    Google Scholar
  • 3a Gehringer MM. FEBS Lett.  2004,  557:  1 
    Google Scholar
  • 3b Pihko PM. Aho JE. Org. Lett.  2004,  6:  3849 
    Google Scholar
  • 3c Evans DA. Rajapakse HA. Chiu A. Stenkamp D. Angew. Chem. Int. Ed.  2002,  41:  4573 ; Angew. Chem. 2002, 114, 4755
    Google Scholar
  • 4 Katagiri K. Tori K. Kimura Y. Yoshida T. Nagasaki T. Minato H. J. Med. Chem.  1967,  10:  1149 
    CrossrefPubMedGoogle Scholar
  • 5a Tanaka K. Tomaki M. Watanabe S. Biochim. Biophys. Acta  1969,  159:  244 
    Google Scholar
  • 5b Kohno T. Kohda D. Haruki M. Yokoyama S. J. Biol. Chem.  1990,  12:  6931 
    Google Scholar
  • 5c Kazmaier U. Pähler S. Endermann R. Häbich D. Kroll H.-P. Riedl B. Bioorg. Med. Chem.  2002,  10:  3905 
    Google Scholar
  • 6a Sakai R. Kamiyla H. Murata M. Shimamoto K. J. Am. Chem. Soc.  1997,  119:  4112 
    Google Scholar
  • 6b Sakai R. Koike T. Sasaki M. Shimamoto K. Oiwa C. Yano A. Suzuki K. Tachibana K. Kamiya H. Org. Lett.  2001,  3:  1479 
    Google Scholar
  • 6c Sanders J. Ito K. Settimo L. Pentikainen O. Shoji M. Sasaki M. Johnson M. Sakai R. Swanson G. J. Pharmacol. Exp. Ther.  2005,  314:  1068 
    Google Scholar
  • 7 Review: Moloney MG. Nat. Prod. Rep.  2002,  19:  597 ; and references cited therein
    CrossrefPubMedGoogle Scholar
  • Reviews:
  • 8a Kazmaier U. Amino Acids  1996,  11:  283 
    Google Scholar
  • 8b Kazmaier U. Liebigs Ann./Recl.  1997,  285 
    Google Scholar
  • 8c Bauer M. Kazmaier U. Recent Res. Dev. Org. Chem.  2005,  9:  49 ; and references cited therein
    Google Scholar
  • 9a Pohlman M. Kazmaier U. Org. Lett.  2003,  5:  2631 
    Google Scholar
  • 9b Pohlman M. Kazmaier U. Lindner T. J. Org. Chem.  2004,  69:  6909 
    Google Scholar
  • 9c Mendler B. Kazmaier U. Huch V. Veith M. Org. Lett.  2005,  7:  2643 
    Google Scholar
  • 9d Mendler B. Kazmaier U. Synthesis  2005,  2239 
    Google Scholar
  • 10 Kazmaier U. Schmidt C. Synlett  2009,  1136 
    Article in Thieme ConnectGoogle Scholar
  • 11 Kazmaier U. Schmidt C. Synthesis  2009,  2435 
    Article in Thieme ConnectGoogle Scholar
  • 12 Schmidt C. Kazmaier U. Org. Biomol. Chem.  2008,  6:  4643 
    CrossrefGoogle Scholar
  • 13 Schmidt C. Kazmaier U. Eur. J. Org. Chem.  2008,  887 
    CrossrefGoogle Scholar
14

Michael Product 8
¹H NMR (500 MHz, CDCl3): δ = 1.47 (s, 9 H), 2.82-2.88 (m, 1 H), 3.58 (dd, J = 11.5, 6.4 Hz, 1 H), 3.63 (dd, J = 11.5, 6.2 Hz, 1 H), 3.65-3.69 (m, 1 H), 3.70 (s, 3 H), 4.72 (dd, J = 4.9, 8.2 Hz, 1 H), 7.62 (d, J = 8.2 Hz, 1 H). ¹³C NMR (125 MHz, CDCl3): δ = 27.9 (q), 33.0 (t), 39.6 (t), 44.5 (d), 52.3 (q), 54.1 (d), 84.2 (s), 115.7 (q, J = 287.7 Hz), 157.4 (q, J = 37.6 Hz), 168.2 (s), 172.4 (s). HRMS (CI): m/z calcd for C13H20NO5F3Cl [M + H]+: 362.0937; found: 362.1010.

15

Cyclopropyl Amino Acid 9
¹H NMR (500 MHz, CDCl3): δ = 1.06 (ddd, J = 8.9, 5.7, 5.7 Hz, 1 H), 1.29 (ddd, J = 9.2, 5.2, 5.2 Hz, 1 H), 1.49 (s, 9 H), 1.71-1.75 (m, 1 H), 1.84 (dt, J = 8.8, 4.6 Hz, 1 H), 3.67 (s, 3 H), 4.07-4.12 (m, 1 H), 6.98 (d, J = 7.9 Hz, 1 H). ¹³C NMR (125 MHz, CDCl3): δ = 12.7 (t), 17.7 (d), 23.6 (d), 27.5 (q), 51.8 (q), 54.3 (d), 83.8 (s), 115.4 (q, J = 287.8 Hz), 156.6 (q, J = 37.6 Hz), 168.2 (s), 173.0 (s). HRMS (CI): m/z calcd for C13H19F3NO5 [M + H]+: 326.1215; found: 326.1258. Anal. Calcd for C13H18F3NO5 (325.28): C, 48.00; H, 5.58; N, 4.31. Found: C, 48.07; H, 5.39; N, 4.28.

16

Michael-Aldol Product 10a
Major diastereomer: ¹H NMR (500 MHz, CDCl3): δ = 1.50 (s, 9 H), 3.08-3.12 (m, 1 H), 3.19 (dd, J = 9.9, 4.4 Hz, 1 H), 3.66 (br s, 1 H), 3.41 (s, 3 H), 3.91 (dd, J = 12.1, 4.0 Hz, 1 H), 4.00 (dd, J = 12.1, 5.9 Hz, 1 H), 4.81 (dd, J = 8.4, 4.6 Hz, 1 H), 5.10 (d, J = 4.4 Hz, 1 H), 7.24-7.34 (m, 6 H). ¹³C NMR (125 MHz, CDCl3): δ = 27.8 (q), 41.8 (d), 43.8 (t), 50.6 (d), 52.0 (s), 53.7 (d), 71.3 (d), 84.4 (s), 115.6 (q, J = 287.8 Hz), 124.9 (d), 128.4 (d), 127.8 (d), 140.8 (s), 156.9 (q, J = 38.0 Hz), 168.2 (s), 173.4 (s).
Minor diastereomer: ¹H NMR (500 MHz, CDCl3): δ = 1.47 (s, 9 H), 2.90-2.95 (m, 1 H), 3.01 (dd, J = 9.8, 1.4 Hz, 1 H), 3.08 (br s, 1 H), 3.40 (s, 3 H), 3.73 (t, J = 10.9 Hz, 1 H), 4.11 (dd, J = 19.9, 5.0 Hz, 1 H), 4.91 (d, J = 9.8 Hz, 1 H), 4.95 (dd, J = 8.4, 4.8 Hz, 1 H), 7.26-7.35 (m, 5 H), 9.05 (d, J = 8.3 Hz, 1 H). ¹³C NMR (125 MHz, CDCl3): δ = 27.8 (q), 41.6 (t), 42.8 (d), 52.1 (d), 52.3 (s), 52.5 (d), 71.8 (d), 83.5 (s), 115.6 (q, J = 287.8 Hz), 126.6 (d), 128.8 (d), 129.1 (d), 140.3 (s), 156.9 (q, J = 38.0 Hz), 168.5 (s), 172.0 (s).

17

General Procedure for Domino Michael-Aldol Additions-Cyclizations In a Schlenk flask HMDS (0.3 mL, 1.42 mmol) was dissolved in THF (2 mL). The solution was cooled to -78 ˚C before n-BuLi (1.6 M, 0.78 mL, 1.25 mmol) was added. The cooling bath was removed and the solution was allowed to warm up for 15 min, before it was cooled again to -90 ˚C. In a second Schlenk flask ZnCl2 (80 mg, 0.57 mmol) was dried with a heat gun under high vacuum, before it was dissolved in THF (3 mL). After addition of TFA-Gly-Ot-Bu (115 mg, 0.5 mmol) the solution was cooled to -90 ˚C, before the freshly prepared LHMDS solution was added. 20 min later the Michael acceptor (0.42 mmol) was added in THF (2 mL). After 2 h the corresponding aldehyde (0.85 mmol) was added, and the reaction mixture was hold at -60 ˚C for 6 h. After addition of DMPU (1.5 mL) the reaction mixture was allowed to warm to r.t. overnight. The solution was diluted with hexanes-Et2O (9:1) before it was washed twice with NH4Cl (20 mL each). The aqueous phase was extracted twice with CH2Cl2, and the combined organic layers were dried (Na2SO4). After evaporation of the solvent under vacuum the crude product was purified by flash chromatography (silica, hexanes-EtOAc).

18

Spectroscopic and Analytical Data of Selected Products 11a
4,5-syn-11a: ¹H NMR (500 MHz, CDCl3): δ = 1.48 (s, 9 H), 3.19 (s, 3 H), 3.20 (dtd, J = 9.6, 8.9, 7.5 Hz, 1 H), 3.33 (t, J = 8.9 Hz, 1 H), 3.80 (t, J = 9.6 Hz, 1 H), 4.39 (dd, J = 9.2, 7.5 Hz 1 H), 4.53 (t, J = 9.0 Hz, 1 H), 4.91 (d, J = 8.5 Hz, 1 H), 7.01 (d, J = 8.9 Hz, 1 H), 7.20-7.30 (m, 5 H). ¹³C NMR (125 MHz, CDCl3): δ = 27.9 (q), 44.7 (d), 51.7 (q), 53.4 (d), 54.1 (d), 70.9 (t), 82.5 (d), 84.3 (s), 115.6 (q, J = 287.6 Hz), 126.5 (d), 128.0 (d), 128.2 (d), 137.9 (s), 157.0 (q, J = 38.0 Hz), 168.2 (s), 171.8 (s).
4,5-anti-11a: ¹H NMR (500 MHz, CDCl3): δ = 1.46 (s, 9 H), 2.92 (t, J = 8.2 Hz, 1 H), 3.13-3.18 (m, 1 H), 3.68 (s, 3 H), 4.13 (d, J = 7.0 Hz, 2 H), 4.55 (t, J = 8.2 Hz, 1 H), 4.96 (d, J = 8.4 Hz, 1 H), 7.13 (d, J = 8.2 Hz, 1 H), 7.20-7.36 (m, 5 H). ¹³C NMR (125 MHz, CDCl3): δ = 46.7 (d), 52.5 (q), 55.2 (d), 55.2 (d), 70.3 (t), 83.9 (d), 84.2 (s), 115.6 (q, J = 287.6 Hz), 125.8 (d), 128.6 (d), 128.2 (d), 139.2 (s), 157.0 (q, J = 38.0 Hz), 168.2 (s), 171.8 (s). HRMS (CI): m/z calcd for C20H25F3NO6 [M + H]+: 432.1634; found: 432.1658. Anal. Calcd for C20H24F3NO6 (431.41): C, 55.68; H, 5.61; N, 3.25. Found: C, 55.63; H, 5.61; N, 3.04.